Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Expenses (2016 - 2017)

Historic Accumulated Expenses for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to $223088.0.

  • Tenax Therapeutics' Accumulated Expenses fell 9334.9% to $223088.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $223088.0, marking a year-over-year decrease of 9334.9%. This contributed to the annual value of $5.2 million for FY2016, which is N/A changed from last year.
  • Tenax Therapeutics' Accumulated Expenses amounted to $223088.0 in Q3 2017, which was down 9334.9% from $1.7 million recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Accumulated Expenses ranged from a high of $5.2 million in Q4 2016 and a low of $223088.0 during Q3 2017
  • In the last 4 years, Tenax Therapeutics' Accumulated Expenses had a median value of $3.1 million in 2015 and averaged $2.5 million.
  • As far as peak fluctuations go, Tenax Therapeutics' Accumulated Expenses surged by 6894.92% in 2016, and later plummeted by 9334.9% in 2017.
  • Over the past 4 years, Tenax Therapeutics' Accumulated Expenses (Quarter) stood at $874876.0 in 2013, then skyrocketed by 254.89% to $3.1 million in 2015, then soared by 68.95% to $5.2 million in 2016, then crashed by 95.75% to $223088.0 in 2017.
  • Its Accumulated Expenses was $223088.0 in Q3 2017, compared to $1.7 million in Q2 2017 and $3.6 million in Q1 2017.